Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-04-12A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia (12 Weeks Treatment Study)
-
CLINICAL_TRIALS study record update · 2021-04-12A Double-Blind, Placebo-Controlled Study of MP-214 in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-04-12Long-Term Extension Study of MP-214 in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-04-12Effect of rTMS Over the Medial Cerebellum on Negative Symptoms and Cognitive Dysmetria in Subjects With Treatment Refractory Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-04-09Assessing a WeChat-based Integrative Family Intervention (WIFI) for Schizophrenia: a Stepped-wedge Cluster Randomized Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-04-09A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Phase I Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of CY150112 After Single Oral Administration in Healthy Chinese Subjects
-
CLINICAL_TRIALS study record update · 2021-04-08Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers
-
CLINICAL_TRIALS study record update · 2021-04-01The Effect of Psychoeducation Based On Uncertainty In Illness Theory On Intolerance To Uncertainty, Psychological Wellbeing And Coping Styles In Schizophrenia Caregivers
-
CLINICAL_TRIALS study record update · 2021-03-29The Appeal and Impact of E-cigarettes in Smokers With Serious Mental Illness
-
CLINICAL_TRIALS study record update · 2021-03-29A Multiple-dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and QTc Effect of MK-8189 in Participants With Schizophrenia and Healthy Participants.
-
CLINICAL_TRIALS study record update · 2021-03-03Large Scale Implementation of Community Based Mental Health Care for People With Severe and Enduring Mental Ill Health in Europe
-
CLINICAL_TRIALS study record update · 2021-03-02Comparison of the Effectiveness of the Virtual Environment in Cognitive Rehabilitation With Standard Rehabilitation Methods in Patients With Schizophrenia and in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2021-03-01A Randomized, Double -Blind, Placebo-Controlled, Phase 1, Ascending Oral Single and Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAK-041 in Healthy Subjects and Subjects With Stable Schizophrenia and a Randomized Open-Label, Single Dose, Parallel Design to Evaluate the Relative Bioavailability and Effect of Food on the Pharmacokinetics of TAK-041 Tablet Formulation in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2021-03-01Lurasidone Effects on Tissue Glutamate in Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-02-26Brain Imaging, Cognitive Enhancement and Early Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-02-24A Multi-Center Study of Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects
-
CLINICAL_TRIALS study record update · 2021-02-24A Phase II Randomised, Double-blinded, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of 4 Oral Doses of BI 425809 Once Daily Over 12 Week Treatment Period in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-02-23The Factors Related to Occupational Outcome Among Persons With Mental Illness Under the Peer-support Service in Vocational Rehabilitation Program: a Pilot Study
-
CLINICAL_TRIALS study record update · 2021-02-21A Multicenter, Double-Blind, Randomized Trial Of Ziprasidone (80 - 160 Mg) Versus Olanzapine (10 - 20 Mg) In Patients With Recent-Onset Schizophrenia, Schizoaffective And Schizophreniform Disorder.
-
CLINICAL_TRIALS study record update · 2021-02-2112 Week Open Label, Multicenter, Non-Comparative Switch Study Evaluating Efficacy, Tolerability And Safety Of Oral Ziprasidone In Treatment Of Patients Suffering From Schizophrenia Who Have Already Been Treated With An Other Antipsychotic.
-
CLINICAL_TRIALS study record update · 2021-02-21An Open Trial to Evaluate the Efficacy and Tolerability of Ziprasidone IM and Oral in Patients With Psychosis and Acute Agitation.
-
CLINICAL_TRIALS study record update · 2021-02-21A Multi-Center Study To Examine The Clinical Effects Of Cross Titration Of Antipsychotics With Ziprasidone In Subjects With Schizophrenia Or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2021-02-21A 27-Week Open-Label Trial To Characterize The Safety And Tolerability Of Orally Administered Ziprasidone In Children And Adolescent Subjects With Bipolar I Disorder (Manic Or Mixed), Schizophrenia Or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2021-02-21A Six Week, Multicenter, Double Blind, Double-Dummy, Parallel, Comparative Study To Compare The Efficacy, Safety And Tolerability Of Ziprasidone With Risperidone In The Treatment Of Chinese Subjects With Acute Exacerbation Of Schizophrenia
-
CLINICAL_TRIALS study record update · 2021-02-21Ziprasidone Versus Risperidone In The Treatment Of Chronic Schizophrenia: A Six Months, Double Blind Randomized, Parallel Group Study